Pieris Pharmaceuticals Stock Discussion

$Pieris Pharmaceuticals (PIRS.US)$ Palvella Therapeutics Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development to Support Phase 3 Single-Arm, Baseline-Controlled Trial in Microcystic Lymphatic Malformations
3 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
FDA Orphan Products Grants are based on scientific and technical merit as determined by rare disease and regulatory experts
Ongoing Phase 3 trial evaluating QTORIN™ 3.9% rapamycin...

$Pieris Pharmaceuticals (PIRS.US)$ Shareholder Alert: Ademi LLP investigates whether Pieris Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders
PRNewswire 24-Jul-2024 2:55 PM
This firm never misses a merger! Dont know if they do good work on not but Damn! Its every one! Hehehe

$Pieris Pharmaceuticals (PIRS.US)$ Sell.

$Pieris Pharmaceuticals (PIRS.US)$ Break 17.53? looking for 18.85 and 19.97 NFA